Genetic testing presents major growth opportunities in predictive diagnostics, pharmacogenomic testing, and direct-to-consumer markets. With increasing test volumes and lower prices, the industry is ...

Richard Hammond returns to the driver’s seat for another driving test — years after first passing it. This video follows his ...

Highlights Third quarter 2025 revenue of $205.7 million decreased by 4% year-over-year but was flat when excluding previously discussed headwinds1 of $8.1 million, consistent with management ...

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis ...

The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...

Published in the Oct. 30, 2025 edition of Frontiers in Pharmacology, the new post-hoc analysis showed that patients who took the GeneSight test were at any given time during the 24-week study period ...

The Cancer Molecular Diagnostics market is seeing accelerated growth driven by trends like personalized medicine, pharmacogenomics, and liquid biopsy. Key opportunities lie in companion diagnostics, ...

PRIME Care met both of its prespecified primary outcomes: patients in the PGx-guided arm were less likely to be prescribed an antidepressant medication with a significant gene-drug interaction and ...

Q3 2025 Earnings Call Transcript November 4, 2025 SOPHiA GENETICS S.A. misses on earnings expectations. Reported EPS is $-0.3 ...

Guardant Health, Inc. shows strong adoption and revenue growth in oncology and data. Click for my updated look at GH stock ...

Genetic testing is transforming healthcare through personalized medicine, enabling early diagnosis, targeted treatments, and ...